CoChat
Sign Up
Cited by 198

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts

Kamiya, Nobuhiro, Kobayashi, Tatsuya, Mochida, Yoshiyuki, Yu, Paul B, Yamauchi, Mitsuo, Kronenberg, Henry M, Mishina, Yuji·2010·Journal of Bone and Mineral Research
DOI 10.1359/jbmr.090806PMC PMC3153381
Open this paper in CoChat — free account

Abstract

The bone morphogenetic protein (BMP) and Wnt signaling pathways both contribute essential roles in regulating bone mass. However, the molecular interactions between these pathways in osteoblasts are poorly understood. We recently reported that osteoblast-targeted conditional knockout (cKO) of BMP receptor type IA (BMPRIA) resulted in increased bone mass during embryonic development, where diminished expression of Sost as a downstream effector of BMPRIA resulted in increased Wnt/β-catenin signaling. Here, we report that Bmpr1a cKO mice exhibit increased bone mass during weanling stages, again with evidence of enhanced Wnt/β-catenin signaling as assessed by Wnt reporter TOPGAL mice and TOPFLASH luciferase. Consistent with negative regulation of the Wnt pathway by BMPRIA signaling, treatment of osteoblasts with dorsomorphin, an inhibitor of Smad-dependent BMP signaling, enhanced Wnt signaling. In addition to Sost, Wnt inhibitor Dkk1 also was downregulated in cKO bone. Expression levels of Dkk1and Sost were upregulated by BMP2 treatment and downregulated by Noggin. Moreover, expression of a constitutively active Bmpr1a transgene in mice resulted in the upregulation of both Dkk1 and Sost and partially rescued the Bmpr1a cKO bone phenotype. These effectors are differentially regulated by mitogen-activated protein kinase (MAPK) p38 because pretreatment of osteoblasts with SB202190 blocked BMP2-induced Dkk1 expression but not Sost. These results demonstrate that BMPRIA in osteoblasts negatively regulates endogenous bone mass and Wnt/β-catenin signaling and that this regulation may be mediated by the activities of Sost and Dkk1. This study highlights several interactions between BMP and Wnt signaling cascades in osteoblasts that may be amenable to therapeutic intervention for the modification of bone mass density. © 2010 American Society for Bone and Mineral Research

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1359/jbmr.090806

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 71

  1. Massague, 1992, Receptors for the TGF-β family, Cell., 69, 1067, 10.1016/0092-8674(92)90627-O · DOI
  2. Wrana, 1994, Mechanism of activation of the TGF-β receptor, Nature., 370, 341, 10.1038/370341a0 · DOI
  3. Urist, 1965, Bone: formation by autoinduction, Science., 150, 893, 10.1126/science.150.3698.893 · DOI
  4. Shi, 2003, Mechanisms of TGF-β signaling from cell membrane to the nucleus, Cell., 113, 685, 10.1016/S0092-8674(03)00432-X · DOI
  5. Keller, 2004, Molecular recognition of BMP-2 and BMP receptor IA, Nat Struct Mol Biol., 11, 481, 10.1038/nsmb756 · DOI
  6. Hatta, 2000, Identification of the ligand-binding site of the BMP type IA receptor for BMP-4, Biopolymers., 55, 399, 10.1002/1097-0282(2000)55:5<399::AID-BIP1014>3.0.CO;2-9 · DOI
  7. Wozney, 1992, The bone morphogenetic protein family and osteogenesis, Mol Reprod Dev., 32, 160, 10.1002/mrd.1080320212 · DOI
  8. Chen, 2004, Bone morphogenetic proteins, Growth Factors., 22, 233, 10.1080/08977190412331279890 · DOI
  9. Shore, 2006, A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva, Nat Genet., 38, 525, 10.1038/ng1783 · DOI
  10. Yu, 2008, BMP type I receptor inhibition reduces heterotopic [corrected] ossification, Nat Med., 14, 1363, 10.1038/nm.1888 · DOI
  11. Zhang, 1996, Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development, Development., 122, 2977, 10.1242/dev.122.10.2977 · DOI
  12. Winnier, 1995, Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse, Genes Dev., 9, 2105, 10.1101/gad.9.17.2105 · DOI
  13. Mishina, 1995, Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis, Genes Dev., 9, 3027, 10.1101/gad.9.24.3027 · DOI
  14. Kamiya, 2008, BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway, Development., 135, 3801, 10.1242/dev.025825 · DOI
  15. Kamiya, 2008, Disruption of BMP signaling in osteoblasts through type IA receptor (BMPRIA) increases bone mass, J Bone Miner Res., 23, 2007, 10.1359/jbmr.080809 · DOI
  16. Harada, 2003, Control of osteoblast function and regulation of bone mass, Nature., 423, 349, 10.1038/nature01660 · DOI
  17. Baron, 2006, Wnt signaling: a key regulator of bone mass, Curr Top Dev Biol., 76, 103, 10.1016/S0070-2153(06)76004-5 · DOI
  18. Hartmann, 2006, A Wnt canon orchestrating osteoblastogenesis, Trends Cell Biol., 16, 151, 10.1016/j.tcb.2006.01.001 · DOI
  19. Glass, 2006, Molecular bases of the regulation of bone remodeling by the canonical Wnt signaling pathway, Curr Top Dev Biol., 73, 43, 10.1016/S0070-2153(05)73002-7 · DOI
  20. Rawadi, 2003, BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop, J Bone Miner Res., 18, 1842, 10.1359/jbmr.2003.18.10.1842 · DOI
  21. Bain, 2003, Activated β-catenin induces osteoblast differentiation of C3H10T1/2 cells and participates in BMP2-mediated signal transduction, Biochem Biophys Res Commun., 301, 84, 10.1016/S0006-291X(02)02951-0 · DOI
  22. Mbalaviele, 2005, β-Catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation, J Cell Biochem., 94, 403, 10.1002/jcb.20253 · DOI
  23. Winkler, 2005, Sclerostin inhibition of Wnt-3a-induced C3H10T1/2 cell differentiation is indirect and mediated by bone morphogenetic proteins, J Biol Chem., 280, 2498, 10.1074/jbc.M400524200 · DOI · Paper page
  24. Nakashima, 2005, Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts, J Biol Chem., 280, 37660, 10.1074/jbc.M504612200 · DOI
  25. Simpson, 2006, The role of growth factors and related agents in accelerating fracture healing, J Bone Joint Surg Br., 88, 701, 10.1302/0301-620X.88B6.17524 · DOI
  26. Mishina, 2002, Generation of Bmpr/Alk3 conditional knockout mice, Genesis., 32, 69, 10.1002/gene.10038 · DOI
  27. Soriano, 1999, Generalized lacZ expression with the ROSA26 Cre reporter strain, Nat Genet., 21, 70, 10.1038/5007 · DOI
  28. DasGupta, 1999, Multiple roles for activated LEF/TCF transcription complexes during hair follicle development and differentiation, Development., 126, 4557, 10.1242/dev.126.20.4557 · DOI
  29. Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(–ΔΔC(t)) method, Methods., 25, 402, 10.1006/meth.2001.1262 · DOI · Paper page
  30. Fujita, 2004, Hormonal regulation of metastasis-associated protein 3 transcription in breast cancer cells, Mol Endocrinol., 18, 2937, 10.1210/me.2004-0258 · DOI
  31. Yu, 2008, Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism, Nat Chem Biol., 4, 33, 10.1038/nchembio.2007.54 · DOI
  32. Ai, 2005, Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling, Mol Cell Biol., 25, 4946, 10.1128/MCB.25.12.4946-4955.2005 · DOI
  33. Li, 2005, Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation, Nat Genet., 37, 945, 10.1038/ng1614 · DOI
  34. Patel, 2002, Regulation of bone formation and vision by LRP5, N Engl J Med., 346, 1572, 10.1056/NEJM200205163462011 · DOI
  35. Semenov, 2005, SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor, J Biol Chem., 280, 26770, 10.1074/jbc.M504308200 · DOI · Paper page
  36. Bodine, 2004, The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice, Mol Endocrinol., 18, 1222, 10.1210/me.2003-0498 · DOI
  37. Miyazono, 1999, Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins, Bone., 25, 91, 10.1016/S8756-3282(99)00113-1 · DOI
  38. Fujii, 1999, Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation, Mol Biol Cell., 10, 3801, 10.1091/mbc.10.11.3801 · DOI
  39. Xu, 2008, Ectodermal Smad4 and p38 MAPK are functionally redundant in mediating TGF-β/BMP signaling during tooth and palate development, Dev Cell., 15, 322, 10.1016/j.devcel.2008.06.004 · DOI
  40. Zuzarte-Luis, 2004, A new role for BMP5 during limb development acting through the synergic activation of Smad and MAPK pathways, Dev Biol., 272, 39, 10.1016/j.ydbio.2004.04.015 · DOI
  41. Tseng, 2008, New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure, Nature., 454, 1000, 10.1038/nature07221 · DOI · Paper page
  42. Inagaki, 2009, p38-Mitogen-activated protein kinase stimulated steroidogenesis in granulosa cell-oocyte cocultures: role of bone morphogenetic proteins 2 and 4, Endocrinology., 150, 1921, 10.1210/en.2008-0851 · DOI
  43. Huelsken, 2001, β-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin, Cell., 105, 533, 10.1016/S0092-8674(01)00336-1 · DOI
  44. Barrow, 2003, Ectodermal Wnt3/β-catenin signaling is required for the establishment and maintenance of the apical ectodermal ridge, Genes Dev., 17, 394, 10.1101/gad.1044903 · DOI
  45. Guo, 2004, Wnt/β-catenin signaling is sufficient and necessary for synovial joint formation, Genes Dev., 18, 2404, 10.1101/gad.1230704 · DOI
  46. He, 2004, BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-β-catenin signaling, Nat Genet., 36, 1117, 10.1038/ng1430 · DOI
  47. Dean, 2005, Canonical Wnt signaling negatively regulates branching morphogenesis of the lung and lacrimal gland, Dev Biol., 286, 270, 10.1016/j.ydbio.2005.07.034 · DOI
  48. Zhang, 2006, Bone morphogenetic protein signaling inhibits hair follicle anagen induction by restricting epithelial stem/progenitor cell activation and expansion, Stem Cells., 24, 2826, 10.1634/stemcells.2005-0544 · DOI
  49. Chen, 2007, Beta-catenin signaling pathway is crucial for bone morphogenetic protein 2 to induce new bone formation, J Biol Chem., 282, 526, 10.1074/jbc.M602700200 · DOI
  50. Mukhopadhyay, 2001, Dickkopf1 is required for embryonic head induction and limb morphogenesis in the mouse, Dev Cell., 1, 423, 10.1016/S1534-5807(01)00041-7 · DOI
  51. Grotewold, 2002, The Wnt antagonist Dickkopf-1 is regulated by BMP signaling and c-Jun and modulates programmed cell death, EMBO J., 21, 966, 10.1093/emboj/21.5.966 · DOI
  52. Sutherland, 2004, Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation, Bone., 35, 828, 10.1016/j.bone.2004.05.023 · DOI
  53. Ohyama, 2004, Spaciotemporal association and bone morphogenetic protein regulation of sclerostin and osterix expression during embryonic osteogenesis, Endocrinology., 145, 4685, 10.1210/en.2003-1492 · DOI
  54. Semenov, 2001, Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6, Curr Biol., 11, 951, 10.1016/S0960-9822(01)00290-1 · DOI · Paper page
  55. Morvan, 2006, Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass, J Bone Miner Res., 21, 934, 10.1359/jbmr.060311 · DOI
  56. Li, 2006, Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia, Bone., 39, 754, 10.1016/j.bone.2006.03.017 · DOI
  57. Tian, 2003, The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma, N Engl J Med., 349, 2483, 10.1056/NEJMoa030847 · DOI
  58. Li, 2008, Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength, J Bone Miner Res., 23, 860, 10.1359/jbmr.080216 · DOI
  59. Brunkow, 2001, Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein, Am J Hum Genet., 68, 577, 10.1086/318811 · DOI · Paper page
  60. Balemans, 2002, Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease, J Med Genet., 39, 91, 10.1136/jmg.39.2.91 · DOI · Paper page
  61. Staehling-Hampton, 2002, A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population, Am J Med Genet., 110, 144, 10.1002/ajmg.10401 · DOI
  62. Suzuki, 2002, Evidence for a role of p38 MAP kinase in expression of alkaline phosphatase during osteoblastic cell differentiation, Bone., 30, 91, 10.1016/S8756-3282(01)00660-3 · DOI
  63. Yuge, 2003, Physical stress by magnetic force accelerates differentiation of human osteoblasts, Biochem Biophys Res Commun., 311, 32, 10.1016/j.bbrc.2003.09.156 · DOI
  64. Yuge, 2003, Cell differentiation and p38(MAPK) cascade are inhibited in human osteoblasts cultured in a three-dimensional clinostat, In Vitro Cell Dev Biol Anim., 39, 89, 10.1290/1543-706X(2003)039<0089:CDAPCA>2.0.CO;2 · DOI
  65. Lee, 2008, Integrin-mediated expression of bone formation-related genes in osteoblast-like cells in response to fluid shear stress: roles of extracellular matrix, Shc, and mitogen-activated protein kinase, J Bone Miner Res., 23, 1140, 10.1359/jbmr.080302 · DOI
  66. Wingerter, 2007, Evaluation of short-term healing following sustained delivery of osteoinductive agents in a rat femur drill defect model, Biomed Sci Instrum., 43, 188
  67. Gautschi, 2007, Bone morphogenetic proteins in clinical applications, Aust NZ J Surg., 77, 626, 10.1111/j.1445-2197.2007.04175.x · DOI
  68. Yoon, 2005, Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo, Proc Natl Acad Sci USA., 102, 5062, 10.1073/pnas.0500031102 · DOI
  69. Bandyopadhyay, 2006, Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis, PLoS Genet., 2, e216, 10.1371/journal.pgen.0020216 · DOI
  70. Tsuji, 2006, BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing, Nat Genet., 38, 1424, 10.1038/ng1916 · DOI
  71. Rountree, 2004, BMP receptor signaling is required for postnatal maintenance of articular cartilage, PLoS Biol., 2, e355, 10.1371/journal.pbio.0020355 · DOI

Cited by

Sorted by citations

Metadata

Authors
Kamiya, N., Kobayashi, T., Mochida, Y., Yu, P. B., Yamauchi, M., Kronenberg, H. M., & Mishina, Y.
Affiliations
  • Center for Excellence in Hip Disorders, Texas Scottish Rite Hospital for Children, Dallas, TX, USA
  • Endocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • Dental Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
  • Division of Cardiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • Laboratory of Reproductive and Developmental Toxicology, NIEHS, National Institute of Health, Research Triangle Park, NC, USA
Venue
Journal of Bone and Mineral Research
Publisher
Oxford University Press (OUP)
Published
2010-01-19
Volume
25
Issue
2
Pages
200-210
ISSN
  • 0884-0431
  • 1523-4681
DOI
10.1359/jbmr.090806
PMC
PMC3153381
Cited by
198
References
4
Language
en
Licence
academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review